Provera (medroxyprogesterone): Reviews and patient testimonials
Medication indications
Provera 10 mg Tablets
Progestogen. Indicated for dysfunctional (anovulatory) uterine bleeding, secondary amenorrhoea and for mild to moderate endometriosis.
Provera 5mg
Progestogen. Indicated for dysfunctional (anovulatory) uterine bleeding, secondary amenorrhoea and for mild to moderate endometriosis.
Provera Tablets 100 mg
Progestogen indicated for the treatment of certain hormone dependant neoplasms, such as:
1. Endometrial carcinoma.
2. Renal cell carcinoma.
3. Carcinoma of breast in post menopausal women.
Provera Tablets 2.5 mg
Progestogen. Indicated for dysfunctional (anovulatory) uterine bleeding, secondary amenorrhoea and for mild to moderate endometriosis.
Provera Tablets 200 mg
Progestogen indicated for the treatment of certain hormone dependant neoplasms, such as:
1. Endometrial carcinoma.
2. Renal cell carcinoma.
3. Carcinoma of breast in post menopausal women.
Provera Tablets 400 mg
Progestogen indicated for the treatment of certain hormone dependant neoplasms, such as:
1. Endometrial carcinoma.
2. Renal cell carcinoma.
3. Carcinoma of breast in post menopausal women.
Route of administration: Oral
Molecule: medroxyprogesterone
Patients' opinions on Provera
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.